1800 202 8726
Thyroid cancer follow-up

PET-CT Scan for Thyroid Cancer: — When Is It Actually Needed?

A rising thyroglobulin result after thyroid cancer treatment — especially when the radioiodine scan is clear — can be frightening and difficult to make sense of. PET-CT is the next step in that specific situation. It is designed to find cancer cells that have changed their biology and are now invisible to the radioiodine scan.

Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed September 2026

  • Not the routine scan — After treatment, radioiodine scans and thyroglobulin blood tests are the standard monitoring tools, not PET-CT.
  • A specific trigger — PET-CT is ordered when thyroglobulin is rising but the radioiodine scan shows nothing.
  • Cancer that has changed — This pattern points to cells that have stopped absorbing iodine — which PET-CT is designed to find.
  • Biopsy still confirms — A PET-CT finding guides where to look next, but tissue biopsy confirms whether it is cancer.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get this explained properly

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

PET-CT is not the routine follow-up scan after thyroid cancer treatment. The standard approach uses radioiodine scans and thyroglobulin blood tests. PET-CT becomes useful when your thyroglobulin level is rising but the radioiodine scan shows nothing — a pattern that points to cancer cells that no longer absorb iodine.

CION's PET-CT scans in Hyderabad start at Rs 10,499 — among the lowest published prices in the city, with no hidden charges. Indicative price, as of September 2026.

What is the usual monitoring path after thyroid cancer?

  1. Thyroidectomy

    Surgery to remove the thyroid gland is the starting point for most thyroid cancer treatment.

  2. Radioiodine therapy

    Radioiodine treatment may follow surgery to destroy remaining thyroid tissue. Your oncologist decides whether you need it based on your risk.

  3. Thyroglobulin monitoring

    Thyroglobulin is a protein made only by thyroid cells. After a complete thyroidectomy it should become undetectable. A level that rises in your blood tests is the earliest signal that cancer cells may be returning.

  4. Radioiodine whole-body scan

    This scan looks for cancer cells that are still absorbing iodine. If it finds something alongside a rising thyroglobulin, your team has a clear picture to plan from.

  5. Rising thyroglobulin but a clear radioiodine scan

    When thyroglobulin rises but the radioiodine scan shows nothing, this is the specific trigger for PET-CT. It suggests cancer cells that have stopped absorbing iodine — and are therefore invisible to the radioiodine scan.

  6. FDG PET-CT

    Cancer cells that stop absorbing iodine often absorb more glucose instead. FDG PET-CT uses a glucose-based tracer to locate them. ATA and EANM guidance both recognise this as the defined indication for PET-CT in thyroid cancer.

Why does a rising thyroglobulin with a clear iodine scan point to PET-CT?

Thyroglobulin rising after treatment tells your team that cancer cells are active somewhere in the body. The radioiodine scan not finding them means those cells have stopped absorbing iodine.

This happens when cancer cells become less differentiated — they lose the properties of normal thyroid tissue, including iodine absorption. As they lose iodine avidity, they tend to take up glucose more actively.

FDG PET-CT tracks glucose uptake. This is what makes it useful precisely where the radioiodine scan fails — the two tests look at different properties of the same cells.

ATA and EANM guidance both support FDG PET-CT in this setting. It is a defined clinical indication, not a general screening tool for thyroid cancer.

Still unclear?

Send your reports across and a specialist will walk you through what they mean — what is known, what is not, and what the options actually are.

PET-CT Partner Centres

PET-CT Scan Centres in Hyderabad

CION offers PET-CT scans through 4 trusted partner PET-CT centres across Hyderabad, so you can choose the one closest to you. Call 18002028726 and we’ll guide you to the earliest available appointment.

These are partner diagnostic centres within the CION network. Toll-free booking: 18002028726.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a straight answer from a specialist

45 minutes, your reports reviewed, your questions answered in plain language.

Book Free Consultation Call 1800 202 8726

How is PET-CT different from a radioiodine scan?

A radioiodine scan finds cancer cells that still behave like normal thyroid tissue and absorb iodine. It is the right first-line test for well-differentiated thyroid cancer after surgery and radioiodine therapy.

FDG PET-CT finds cells that have stopped behaving like thyroid tissue and are instead consuming more glucose. These are often more aggressive or less differentiated cells.

The two scans are not interchangeable. They look for different cell properties, and in most patients the radioiodine scan remains the appropriate first test in follow-up.

Medullary thyroid cancer is different — it never absorbs iodine, so imaging is approached differently from the start. Your team will tell you which scans apply to your specific diagnosis.

What else should I know about PET-CT for thyroid cancer?

Does PET-CT work for all types of thyroid cancer?

No. FDG PET-CT is most clearly indicated for differentiated thyroid cancer — papillary and follicular — when the disease has become iodine-negative with a rising thyroglobulin. Medullary thyroid cancer never absorbs iodine, so the imaging approach is different from the start. Anaplastic thyroid cancer is managed differently again. Ask your team which type you have been diagnosed with and what the scanning plan looks like for that specific type.

How long after radioiodine treatment should I wait before having a PET-CT?

Radioiodine therapy can cause temporary changes that may affect how a PET-CT reads. A gap between RAI therapy and FDG PET-CT is generally recommended before the scan is arranged. Your treating team will advise on the timing appropriate for your situation. The right interval depends on the dose you were given and your clinical picture — it is not a fixed number that applies to everyone.

What if the PET-CT also shows nothing?

A negative PET-CT alongside a rising thyroglobulin does not mean nothing is present. It may mean the disease is too small or not metabolically active enough for the tracer to detect at that point. Your team will continue monitoring thyroglobulin and reassess in time. This is a situation to discuss with your oncologist — not one to interpret alone from the scan report.

Does a PET-CT finding mean I need surgery straight away?

Not necessarily. A PET-CT shows where metabolically active tissue is present, but it does not by itself determine what comes next. If the scan shows something new, your team may recommend a biopsy to confirm the nature of that tissue before deciding on treatment. The scan guides where to look; tissue confirmation and a clinical decision follow from there.

Did you know?

As differentiated thyroid cancer cells become less like normal thyroid tissue, they tend to lose iodine absorption and gain glucose uptake — a shift recognised in both ATA and EANM guidance.

This is what makes FDG PET-CT and radioiodine scans complementary tools used at different points in the same patient's journey, not alternatives.

Source: American Thyroid Association Management Guidelines for Differentiated Thyroid Cancer; EANM Procedure Guidelines for FDG-PET/CT in Thyroid Cancer

CION does PET-CT in Hyderabad from Rs 10,499 — among the lowest published prices in the city — including an oncologist-reviewed report and a free Rs 950 consultation. Indicative price, as of September 2026.

Explore 100 more PET-CT for Your Cancer Type topics

All PET-CT for Your Cancer Type →

Your next step

Talk to an oncologist about your scan

Your PET-CT report read by a senior oncologist, explained in plain language, with a free 45-minute consultation.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Is PET-CT the standard scan after thyroid cancer treatment?

No. Standard monitoring after thyroid cancer treatment uses radioiodine whole-body scans and thyroglobulin blood tests. PET-CT is ordered for a specific situation: rising thyroglobulin alongside a negative radioiodine scan. Outside that defined indication, ATA guidance does not recommend FDG PET-CT as a routine post-treatment surveillance tool.

What is thyroglobulin and why does it matter?

Thyroglobulin is a protein produced only by thyroid cells, including thyroid cancer cells. After a complete thyroidectomy it should fall to an undetectable level. A level that begins to rise in serial blood tests is the earliest signal that cancer cells may be active somewhere in the body. The trend over time matters more than any single reading, and it drives decisions about whether and when to scan.

What happens if the PET-CT finds something?

A positive area on the scan will be reviewed alongside your thyroglobulin trend, prior imaging, and full disease history. If the finding is in a location where a biopsy is feasible and safe, tissue confirmation is usually sought before treatment decisions are made. The scan identifies where disease may be — it does not replace the step of confirming what that tissue actually is.

Will I need to stop my thyroid hormone medication before the scan?

FDG PET-CT preparation is different from radioiodine scan preparation. For a PET-CT you will typically be asked to fast beforehand, and blood glucose is usually checked before the tracer is given. Do not stop your thyroid hormone medication unless your team specifically tells you to. Follow the preparation instructions your team gives you for your particular scan, rather than anything you have read about radioiodine scan preparation.

Can PET-CT replace the radioiodine scan?

No — and substituting one for the other at the wrong stage would reduce the chance of finding disease early. Radioiodine scans detect iodine-avid disease, which is the common pattern in well-differentiated thyroid cancer after treatment. FDG PET-CT detects iodine-negative, metabolically active disease — a different state that develops in a proportion of patients. The two tests are designed for different situations in the same patient's journey.

Is PET-CT coordinated through CION?

Yes. If your oncologist determines that a PET-CT is indicated, CION coordinates the scan through partner imaging centres. The images are reviewed alongside your full clinical picture so your team can advise on the next steps.

Call now Book free consultation